Mental Health & Substance Abuse Services, Dept. of - As introduced, enacts the "Helping Open Pathways to Effective (HOPE) Treatment Act." - Amends TCA Title 9; Title 33; Title 53; Title 63 and Title 68.

Summary

The HOPE Treatment Act establishes a Tennessee‑led cohort of a drug developer, a research institution and a hospital to conduct FDA‑approved ibogaine trials for opioid use disorder and other conditions. It sets up funding contracts, matching‑fund requirements, reporting, and a revenue‑sharing model that directs at least 5% of IP earnings to the state and creates a mental‑health innovation fund. The law takes effect July 1 2026 and applies only if ibogaine receives FDA approval.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share